Vesicular system as targeted drug delivery system: An overview

International Journal of Pharmacy and Technology

Volumn 3, Issue 2, 2011, Pages 987-1021

  Gupta, Stuti ^a   Singh, Ravindra Pal ^b   Lokwani, Priyanka ^a   Yadav, Sudhir ^a   Gupta, Shivjee K ^a  

^a JAIPUR NATIONAL UNIVERSITY   (India)

^b SURESH GYAN VIHAR UNIVERSITY   (India)

Author keywords

Liposomes; Niosomes; Pharmacosomes; Transfersomes

Indexed keywords

ANTIMONY; ANTINEOPLASTIC AGENT; ASYMMETRIC LIPOSOME; DRUG CARRIER; GIANT LIPOSOME; HEMOGLOBIN; INSULIN; LARGE UNILAMELLAR LIPOSOME; LIPOSOME; MULTILAMELLAR LIPOSOME; MULTIVESICULAR LIPOSOME; NIOSOME; PEPTIDE; PHARMACOSOME; PROLIPOSOME; PRONIOSOME; SMALL UNILAMELLAR LIPOSOME; TRANSFEROSOME; UNCLASSIFIED DRUG;

BUBBLE METHOD; CALCIUM INDUCED FUSION METHOD; CHEMICAL PROCEDURES; CONFOCAL LASER MICROSCOPY; DEFORMABILITY; DETERGENT DIALYSIS; DETERGENT REMOVAL METHOD; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; EHANOL INJECTION METHOD; ENTRAPMENT EFFICIENCY; ETHER INFUSION METHOD; EVAPORATION; FREEZE DRYING; FREEZE THAWING; FRENCH PRESSURE CELL METHOD; HAND SHAKING METHOD; IMMUNE RESPONSE; IN VITRO DRUG RELEASE; INDUSTRIAL PRODUCTION; LIPID HYDRATION METHOD; MICROFLUIDIZATION; MICROLLUIDIZATION; PERMEABILITY; PHYSICAL PARAMETERS; REVERSE PHASE EVAPORATION METHOD; REVERSE PHASE EVAPORATION TECHNIQUE; REVIEW; SANITATION METHOD; SOLVENT INJECTION METHOD; SOLVENT SPHERULE METHOD; SURFACE CHARGE; TRANSMEMBRANE PH GRADIENT DRUG UPTAKE PROCESS; TURBIDITY; VESICLE DIAMETER; VESICULAR DRUG DELIVERY SYSTEM;

EID: 79960127232     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. nd Edn., Vol 29, Marcel Dekker, Inc., NY, 1987, 7.
2. Ogihara-Umeda I., Sasaki T., Toyama H., Oda K., Senda M. Nishigori H. Cancer Detect Prev., 1997; 21(6):490
3. Park, J.W., Hong, K., Kirpotin, D.B. and Benz C.C., Adv. Pharmacol., 1997, 40, 399.
4. Kao, GY., Change, L.J., Allen, T.M., Cancer Gene Ther. 1996, 3(4), 250-6.
5. Todd, J. A., Modest, E. J., Rossow, P. W. and Tokes, Z. A., Biochem. Pharmacol., 1982, 34, 541.
6. Eible, H., Chem. Phys. Lipids, 1980, 16, 455.
7. Bangham A.D., Standish M.M. and Watlins J.C. (1965). J. Mol. Biol. 13: 238.
8. Bangham A.D., Hill M.W. and Miller N.G.A. (1974). In: Methods in Membrane Biology (Korn N.D., ed.) Plenum. N.Y., Vol.1, p.l.
9. Papahadjopoulos D. and Vail W.J. (1978). Ann. N.Y. Acad. Sci. 308: 259.
10. Gruner S.M., Leak R.P., Janoff S. and Ostro M.J. (1985). Biochem. 24: 2833.
11. Kim S., Jacobs R.E. and White S.H. (1985). Biochim. Biophys. Acta. 812: 793.
12. Oezden M.Y. and Hasirci V.N. (1991). Biochim. Biophys. Acta. 1075: 102.
13. Hamilton R.L. and Guo L.S.S. (1984). In: Liposome Technology (Gregoriadis G. ed.) CRC Press, Florida, Vol.1, Chapter 4, p.37.
14. Lasic D.D., Kidric J. and Zagorc S. (1987). Biochim. Biophys. Acta. 896: 117.
15. Deamer D. and Bangham A.D. (1976). Biochim. Biophys. Acta. 443: 629.
16. Schieren H., Rudolph S., Findelstein M., Coleman P. and Weissmann G. (1978). Biochim. Biophys. Acta. 542: 137.
17. Batzri S. and Korn E.D. (1973). Biochim. Biophy. Acta. 298: 1015.
18. Kagawa Y. and Racker E. (1974). J. Biol. Chem. 246: 5477.
19. Enoch H.G. and Strittmatter P. (1979). Proc. Natl. Acad. Sci. USA. 76: 145.
20. Gerritson W.J., Verkley A.J., Zwaal R.F.A. and van Deenan L.L.M. (1978). Eur. J. Biochem. 85: 255.
21. Philippot J.R., Mutafschicv S. and Liautard J.P. (1985). Biochim. Biophys. Acta. 821: 79.
22. Szoka F and Papahadjopoulos D. (1978). Proc. Natl. Acad. Sci. USA. 75: 4194.
23. Handa T., Takeuchi H., Phokubo Y. and Kawashima Y. (1987). Chem. Pharm. Bull. 35:748.
24. Papahadjopoulos D. and Vail W.J. (1978). Ann. N.Y. Acad. Sci. 308: 259.
25. Mayhew E., Lazo R., Vail WJ, King J. and Green A.M. (1984). Biochim. Biophys. Acta.775: 169.
26. Mayhew E., Lazo R., Vail WJ, King J. and Green A.M. (1984). Biochim. Biophys. Acta.
27. Lasic D.D., Belie A. and Valentincic T. (1988) J. Ant. Client. Soc. 110: 970.
28. Liautard J.P. and Phillippot J.R. (1993). J. Liposomes. 63.
29. Pick U. (1981). Arch. Biochem. Biophys. 212: 186.
30. Oku N., Scheerer J.F. and McDonald R.C. (1982). Biochim. Biophys. Acta. 692: 384.
31. Oku N. and MacDonald R.C. (1983). Biochim. Biophys. Acta. 734: 54.
32. Kim S., Turker M.S., Chi E.Y., Scla S. and Martin G.M. (1983). Biochim. Biophys. Acta.728: 339.
33. Cullis R.P., Hope M.J., Bally M.B., Madden T.D. and Janoff AS. (1987). In: Liposomes from Biophysics to Therapeutics (Ostro M. J., Ed.) Marcel Dekker, N.Y., Chapter 2, p.39.
34. Cestaro B., Pistolesi E., Hershkowitz N. and Galt S. (1982). Biochim. Biophys. Acta. 685:13.
35. Pagano R.E., Martin O.C., Schroit A.J. and Struck D.K. (1981). Biochemistry. 20: 4920.
36. Low M.G. and Zilversmit D.D. (1980). Biochim. Biophys. Acta. 596: 223.
37. Friese J. (1984). In: Liposome Technology (Gregoriadis G., ed.) CRC Press, Florida, Vol.1, Chapter 10, p.131.
38. Maierhofer G. (June 1985). Am. Clinical Products. 33.
39. Payne N.I, Browning I, and Hynes C.A. (1986). J. Pharm. Sci. 75: 330.
40. Crow J.H., Spargo B.J. and Crow L.M. (1987). Proc. Natl. Acad. Sci. USA. 84: 1537.
41. Dapergolas, G. and Gregoriadis, G., Lancet, 1976, 2, 824.
42. Patel, H.M., Stevenson, R.W., Parons, J.A. and Ryman, B.E., Biochim. Biophys. Acta 1982, 716, 188.
43. Patel, H.M. and Ryman, B. E., Biochem. Soc. Trans., 1977, 5, 1739.
44. Hashimoto, A. and Kawada, J., Endocrinol Japan, 1979, 26, 337.
45. Zheng hong, W.V., Qineng P., Yi, W., Jia-ming, L., Acta Pharmacol. Sin., 2004, 25(7), 966.
46. Derycke, A.S. and de Witte, P.A., Adv. Drug. Deliv. Rev., 2004, 56,17.
47. Allen, T. M., Hansen, C. B. and Stuart, D. D., In; Lassic, D. D., Papahadjopoulos, D., Eds., Medical Applications of Liposomes, Elsevier, Amsterdam, 1978, 297.
48. Allen, T. M., Ahmed, I., Lopes de Menezes, D. E. and Moase, E. H., Biochem. Soc. Trans., 1995, 23, 1073.
49. Kirpotin, D. B., In; lasic, D. D., Papahadjopoulos, D. Eds; Medical Applications Of Liposomes, Elsevier, Amsterdam, 1998, 325.
50. Mayer, L. D., Cullis, P. R. and Bally, M. B., In; Lasic, D. D.,Nakhla, T., Marek, M. and Kovalcik, T., Drug Delivery Technology, 2002, 2(4), 135.
51. Bangham, A.D. and R.W. Horne, 1964, Negative staining of phospholipids and their structured modofication by surface active agents as observed in the electron microscope, J. Mol. Biol. 8, 660-668.
52. Papahadjopoulos, D. (ed.), 1978, Liposomes and their use in biology and medicine, Ann. NY Acad. Sci. 308, 1-412.
53. Lasic, D.D., 1992, Liposomes, Am. Sci. 80, 20-31.
54. Lipowsky, R., 1992, The conformation of membranes, Nature 349, 475-481.
55. Lasic, D.D., 1993, Liposomes: From Physics to Applications (Elsevier, Amsterdam) 1993.
56. Gabizon, A., 1989, Liposomes as a drug delivery system in cancer therapy, in: Drug Carrier Systems, eds F.H.D. Roerdink and A.M. Kron (Wiley, Chichester) pp. 185-211.
57. Law, B.A., J.S. King, 1991, Use of liposomes for proteinase addition to cheddar cheese, J. Diary Res. 52, 183-188.
58. Alkhalaf, W., J.C. Piard, M. el Soda, J.C. Gripon, M. Desmezeaud and L. Vassal, 1988, Liposomes as proteinases carriers for the accelerated ripening of St. Paulin type cheese, J. Food Sci. 53, 1674-1679.
59. Kirby, C., 1990, Delivery systems for enzymes, Chem. Br., Sept. 1990, 847-851.
60. Gatt, S., J.H. Bercovier and Y. Barenholz, 1991, Use of liposomes to combat oil spills and their potential application to bioreclamation, in: On Site Bioreclamation, eds R.E. Hinchee and R.F. Olfenbuttel (Butterworth, Stoneham) pp. 293-312.
61. Dutton, G., 1993 (Feb.), The promise of liposomes, Gen. Engin. News, 13, 6-9.
62. Malhotra M. and Jain N.K. Niosomes as Drug Carriers. Indian Drugs (1994), 31 (3): 81-86.
63. Buckton G., Harwood., Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; p.154-155.
64. Baillie A.J., Coombs G.H. and Dolan T.F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate J. Pharm.Pharmacol. 1986; 38: 502-505.
65. Raja Naresh R.A., Chandrashekhar G., Pillai G.K. and Udupa N. Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats. Ind. J. Pharmacol. 1994; 26:46-48.
66. Maver L.D., Bally M.B. Hope., M.J. Cullis P.R. Biochem Biophys. Acta (1985), 816:294-302.
67. Chauhan S. and Luorence M.J. The preparation of polyoxyethylene containing non-ionic surfactant. Vesicles. J. Pharm. Pharmacol. 1989; 41: 6p.
68. Blazek-Walsh A.I. and Rhodes D.G. Pharm. Res. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. 2001; 18: 656-661.
69. Gregoriadis G. Targeting of drugs: implications in medicine. Lancet. 1981; 2(8240): 241-246.
70. Cummings J., Staurt J.F. and Calman K.C. Determination of adriamycin, adriamycinol and their 7- deoxyaglycones in human serum by high-performance liquid chromatography. J. Chromatogr. 1984; 311: 125-133.
71. Hunter C.A., Dolan T.F., Coombs G.H. and Baillie A.J. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J.Pharm. Pharmacol. 1988; 40(3): 161-165.
72. Yoshioka T., Sternberg B., Moody M. and Florence A.T. Niosomes from Span surfactants: Relations between structure and form. J. Pharm. Pharmcol. Supp. 1992; 44: 1044.
73. Brewer J.M. and Alexander J.A. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology. 1992; 75 (4):570-575.
74. Moser P., Marchand-Arvier M., Labrude P., Handjani Vila. R.M. and Vignerson C. Niosomes d'hémoglobine. I. Preparation, proprietes physicochimiques et oxyphoriques, stabilite. Pharma. Acta.Helv. 1989; 64 (7): 192-202.
75. Jayaraman C.S., Ramachandran C. and Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J. Pharm. Sci. 1996; 85 (10): 1082-1084.
76. Azmin M.N., Florence A.T., Handjani-Vila R.M., Stuart J.F.B., Vanlerberghe G., and Whittaker J.S. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J. Pharm. Pharmacol. 1985;37: 237-242.
77. Arun Nanda., Sanju Nanda., Manish Dhall., and Rekha Rao., Transferosomes: A Novel Ultradeformable Vesicular Carrier for Transdermal Drug Delivery, Vol. 5 No. 9 · October 2005, article=395.
78. Jain S., Sapee R., Jain N.K., Proultraflexible lipid vesicles for effective transdermal delivery of norgesterol, Proceedings of 25th conference of C.R.S., U.S.A., 1998: 32-35.
79. Payne R., Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain. Semin on col. 1998:25(7):47-53.
80. Barry B.W., Novel mechanism and device to enable successful transdermal drug delivery, Enr J pharm Sci, 2001:14:101-114.
81. Cevc G., Drug delivery across the skin. Exp. Opin invest Drugs 1997:1887-1973.
82. Cevc G., Lipid vesicles and other colloids as drug carriers on the skin, Adv. Drug delivery Rev 2004: 56(5):675-711.
83. Vaizoglu, O. and Speiser, P. P., Acta Pharm Suec., 1986, 23, 163.
84. Vaizoglu M.O, and Speiser P.P., Pharmacosomes- A Novel Drug Delivery system, Acta Pharm. Suec, 1986, 23, 163-172.
85. Jain N.K., Advances In Controlled and Novel Drug Delivery, 2003, CBS Publishers, New Delhi, India, 276.
86. Volkering F et al., Influence of Nonionic Surfactants on Bioavailability and Biodegradation of Polycyclic Aromatic Hydrocarbons, App. Environ. Micro, 1995, 61(5), 1699-1705.
87. Steve A., Lipophilic Drug Derivatives For Use In Liposomes, US Patent 5534499 (1996).
88. Taskintuna I et al., Evaluation of a Novel Lipid Prodrug for Intraocular Drug Delivery: Effect of Acyclovir Diphosphate Dimyristoylglycerol in a Rabbit Model With Herpes Simplex Virus- Retinitis, Retin, 1997, 17(1), 57-64.
89. Lawrence M.J., Surfactant Systems: Their Use in Drug Delivery, Chem. Soc. Rev, 1994, 23, 417-424.
90. Muller-Goymann C.C and Hamann H.J., Pharmacosomes: Multilamellar Vesicles Consisting of Pure Drug, Eur. J. Pharm. Biopharm, 1991, 37, 113-117.
91. Valentino J., Sand William N.C., Lymphatic Transport of Drugs,1992, CRC Press, Boca Raton, FL, 205
92. Zhang Z.R, Wang J.X and Lu J., Optimization of the Preparation of 3',5' dioctanoyl-5- fluoro- 2'- deoxyuridine Pharmacosomes Using Central Composite Design, Yao Xue Xue Bao, 2001, 36 (6), 456-461.
93. Singh A and Jain R., Targeted Vesicular Constructs For Cytoprotection and Treatment of H. Pylori Infections, US Patent 6576,625 (2003).
94. Steve A., U. S. patent US S, 534, 499 (C1 S14-25, A61K31/70), 1996, 9july, 11.
95. Mantelli S, Speiser P, and Hauser H., Chem. Phys. Lipids, 1985, 37, 329.
96. Yadav J.B., Advanced Practical Physical Chemistry, 1990, Goel Publishing House, Meeruth, India, 74.
97. Mantelli, S., Speiser, P. and Hauser, H., Chem. Phys. Lipids, 1985, 37, 329.
98. Leo, A. and Hansche, F. D., Chem. Rev., 1971, 71, 525.
99. Yadav, J. B., Advanced practical physical chemistry, Goel Publishing house, Meeruth, India, 1990, 74.
100. Steve, A., U. S. patent US S, 534, 499 (C1 S14-25, A61K31/70), 1996, 9july, p 11.
101. Taskintuna, I., Banker, A. S., Flores-Aguilar, M., Lynn, B. G., Alden, K. A., Hostetler, K. Y. and Freeman, W. R., Retina, 1997, 17, 57.
102. Steve A., "Lipophilic Drug Derivatives For Use In Liposomes, US Patent 5534499 (1996).
103. Taskintuna I et al., "Evaluation of a Novel Lipid Prodrug for Intraocular Drug Delivery: Effect of Acyclovir Diphosphate Dimyristoylglycerol in a Rabbit Model With Herpes Simplex Virus- Retinitis, Retin, 1997, 17(1), 57-64.